Partnership between Genes Diffusion and IMV Technologies in the field of pig technologies and equipment for swine artificial insemination

The Genes Diffusion Group and IMV Technologies signed a letter of intent on October 26, 2007, concerning an agreement to transfer Genes Diffusion pig technologies, equipment, and consumables used in the field of artificial insemination to IMV. This agreement also establishes a long-term partnership between the two organizations which will allow both groups to accelerate their grown by developing new biotechnology products in the field of animal reproduction.

On January 1, 2008, IMV Technologies would acquire the Genes Diffusion swine insemination equipment line and semen extenders. This includes world renown products such as Collectis, Gedis and Gedil semen extender. This acquisition would also include in the future the new technology of swine semen encapsulation.

Genes Diffusion would continue to distribute the equipment line and semen extender to the French and Belgian territories. In these territories, swine insemination products, currently available through IMV Technologies (ie; blister bags, AI catheters, extenders, packing machines, and laboratory equipment), would also be available through Genes Diffusion.

With this agreement, IMV Technologies would consolidate its leadership in the development, manufacturing and distribution of swine insemination equipment. Genes Diffusion would emphasize its expertise in the development of biotechnologies in the field of various animal species and would give IMV the right of pre-emption for the distribution of these products worldwide.

This agreement should allow both companies to optimize the strategy of their respective special skills and build a strong privileged partnership. The collaboration between Genes Diffusion and IMV Technologies would increase the emergence of new products and technologies to the customers and distributors of both organizations while respecting existing commitments.

November 23rd, 2007

 

 

Lire actu Read all the news

Your progress is our concern